C ollagen-induced arthritis (CIA)
3 is an animal model of inflammatory arthritis that is caused by immunization of susceptible animals with type II collagen (CII). The disease is strongly linked to the class II immune response genes of the MHC, and in mice high susceptibility is limited to I-A q and I-A r strains (1, 2) . The immunopathogenesis of disease is incompletely understood, but full expression of arthritis depends upon development of both cellular and humoral immunity to CII (3, 4) . Structural characteristics of CII required for induction of arthritis have been studied in some detail (5) . It is known that maintaining CII in its native form during immunization is the most efficient means of inducing arthritis. In rats, native conformation is required (6) . However, in mice, a reasonable incidence of arthritis develops after immunization with denatured CII or with large fragments generated by cyanogen bromide digestion (7, 8) . Identification of specific arthritogenic epitopes has been hampered by the failure of short peptides to induce arthritis. However, there is a substantial body of evidence supporting the concept that T cell recognition of specific epitopes is critical.
In DBA/1 mice, such an epitope has been identified in the CB11 fragment (CII124 -402) of CII (9, 10) . This epitope (CII260 -267) has been studied in detail and is both immunodominant and in the context of CB11 is arthritogenic for I-A q mice. B10.RIII mice (I-A r ) respond to different epitopes. The immunodominant epitope for B10.RIII mice is in CB10 (CII552-897). When B10.RIII mice were immunized with intact CII and when T cell proliferation to CB peptides 8 -12 , which comprise the bulk of CII, was analyzed, the response to CB10 was greater than those elicited against other peptides (11) . Moreover, CB10 induced a more profound suppression when administered i.v. as a tolerogen (11) . The immunodominance of CB10 in B10.RIII mice has been confirmed by Nabozny and coworkers (12) .
However, our previous work has shown that CIA in B10.RIII mice can be induced with CB8 (CII403-551) but not with other CNBr fragments of CII, including CB10 (8) . Thus, the largest CNBr peptide of CII and the one that induced the strongest T cell response in vitro was unable to induce arthritis. These data established that immunogenicity and arthritogenicity were at least partially independent properties. Analysis of the of the immune response to CII by B10.RIII mice using overlapping synthetic peptides identified the core of the major T cell determinant in CB10 to be CII610 -618 (GPAGTAGAR) and that in CB8 to be CII445-453 (GPAGPAGER) (8, 11) . These epitopes are very similar and differ from each other by only two amino acids located at positions 5 and 8. This similarity provided an opportunity to study the structural characteristics that were responsible for arthritogenicity.
In the experiments reported here, we used recombinant DNA technology to generate rCB8, rCB10, and recombinant peptides with alterations in the amino acid residues within the respective T cell determinant cores that differed at the positions where the natural epitopes differed. Using rCB10, we introduced mutations so that the threonine at residue 614 was converted to proline and the alanine at residue 617 to glutamic acid (rCB10 T614P,A617E ). The resulting mutant rCB10 T614P,A617E contained the CB8 T cell determinant but otherwise retained the structure of CB10. Conversely, we introduced mutations into rCB8 so that the proline residue at 449 was converted to threonine and the glutamic acid at position 452 to alanine (rCB8 P449T,E452A ). The resulting rCB8 P449T,E452A contained the CB10 T cell determinant. We then immunized B10.RIII mice with each of the recombinant peptides to answer the question of whether the CB8 epitope would be arthritogenic in another context, i.e., in CB10.
Materials and Methods

Preparation of rCB10 and rCB8 cDNA
Details of the preparation of rCB10 and rCB8 are being published separately (13) . Briefly, chondrocytes were isolated from fetal bovine articular cartilage, and total RNA was isolated from these chondrocytes and used as a template for first strand cDNA synthesis. RT reaction was performed using an RT-PCR kit (Stratagene, La Jolla, CA) according to the manufacturer's directions. After the first strand cDNA synthesis, 5 l of RT reaction mixtures was used to amplify the cDNA encoding the CB8 (CII403-551) and CB10 (CII552-897) regions of CII using primers with the following sequence: CB8, 5Ј-GGGGCTCGAGGGGTCGTGGGCAGCCT-3Ј (forward),5Ј-CCCCCTCGAGTTATCCCCTCTCGCCAGGCAT-3Ј (reverse); and CB10, 5Ј-GGGATCCGGAATGCCTGGCGAGAGGGG AGCA-3 (forward) and 5Ј-GCTCTAGACCATGGGGCCTTGTGCACC AGC-3 (reverse). BamHI and XbaI restriction sites were included in the CB10 primer sequences. A TAG stop codon was also introduced in the reverse primers of both CB8 and CB10. The PCR products for CB8 were directly ligated into the PCR II cloning vector (Invitrogen, Carlsbad, CA). The PCR fragments for CB10 were gel purified, digested with BamHI and XbaI restriction enzymes, and subcloned into the BamHI/XbaI sites of the pUC18 vector. Several clones for both CB8 and CB10 were selected and the inserts were bidirectionally sequenced using a DNA sequencing kit (United States Biochemical, Cleveland, OH).
Mutagenesis was performed by PCR-based site-directed mutation using a PCR in vitro mutagenesis kit (Takara Shuzo/Oncor, Gaithersburg, MD). Three oligonucleotide primers were used to introduce point mutations into the T cell epitope in CB10 cDNA. These changes resulted in the substitution of amino acid residue 614 from threonine to proline (T6143 P) and residue 617 from alanine to glutamic acid (E6173 A). The sequences of the primers were: CB10 T614P , 5Ј-CCTGCTGGACCTGCTGGTG-3Ј; CB10 A617E , 5Ј-ACTGCTGGTGAGCGAGGTGC-3Ј; and CB10 T614P,A617E , 5Ј-CCTGCTGGACCTGCTGGTGAGCGAGGTGC-3Ј. Mutant PCR fragments were amplified from pUC18-CB10 using the combination of primer M13-M4 (supplied in the kit) and one of the CB10 mutant primers, followed by amplification by M13-M4 and M13-RV. The resultant individual PCR products were gel purified, mixed in the same molar ration, and annealed. Heterogeneous double-stranded DNA was completed using Taq. The second round of PCR was conducted using M13-M4 and M13-RV primers to amplify the mutated CB10. The cDNAs were digested with BamHI and HindIII and ligated into the pUC18 vector to obtain pUC18-CB10 T614P , pUC18-CB10 A617E and pUC18-CB10 T614P,A617E . Mutagenesis of CB8 was performed by PCR-based site-directed mutation in a manner identical with that performed for CB10, using the following primer: CB8 P449T,E452A , 5Ј-CTCGCCTCGTGCACCAGCAGTTCCAGCAGG-3Ј.
Expression of rCB10 and rCB8
To express the recombinant proteins, the relevant CB10 cDNA was cut from pUC18 by digestion with BamHI and HindIII. The resulting fragments were subcloned into the pTricHisA vector (Invitrogen) using directional cloning into the multiple cloning site of the vector. Similarly, mutated CB8 PCR fragments were digested with EcoRI, ligated into the same sites of the pTricHisA expression vector (Invitrogen) and sequenced. Top10 hosts (Invitrogen) were transformed with the constructs, and transformants were isolated on selective agar plates. Selected colonies were grown in Luria-Bertani (LB) medium containing ampicillin. The bacteria were expanded, and expression of the relevant proteins was induced with isopropyl ␤-D-thiogalactoside (IPTG). The bacterial cells were harvested, supernatants were clarified, and recombinant proteins were purified by Ni-NTA chromatography following the manufacturer's protocol (Qiagen, Valencia, CA). Fractions were collected and analyzed by 10% SDS-PAGE, and the fractions of interest were pooled, dialyzed against water, lyophilized, and stored at Ϫ20°C. Proteins prepared in this manner were tested for endotoxin using a Limulus assay kit (Sigma. St. Louis, Mo.). If endotoxin was present, the proteins were further purified so that the final endotoxin levels did not exceed 3 U/mg protein.
The proteins were separated by 10% SDS-PAGE and visualized by Coomassie brilliant blue staining. For Western blot analysis, the proteins were separated and electrotransferred onto nitrocellulose membranes. The blots were blocked in 5% nonfat milk/TBS-T buffer (20 mM Tris-HCl (pH 7.6)/150 mM NaCl/0.1% Tween 20) for 2 h and incubated with a specific murine anti-CII antiserum (1:1000 dilution). The blots were washed with TBS-T, incubated with a sheep anti-mouse peroxidase-conjugated Ab (Amersham, Piscataway, NJ), and washed as before. Finally, membranes were subjected to enhanced chemiluminescence detection (ECL kit, Amersham) according to the manufacturer's protocol.
Animals
B10.RIII mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and were maintained in groups of six in polycarbonate cages. They were fed standard rodent chow (Ralston Purina, St. Louis, Mo.) and water ad libitum. The environment was specific pathogen free, and sentinel mice were tested routinely for mouse hepatitis and Sendai viruses.
Immunization
Mice were immunized at 8 -12 wk of age, as described previously (14) . For routine immunization, all Ags were dissolved in 0.01 N acetic acid at a concentration of 4 mg/ml and emulsified with an equal volume of CFA (12) . The resulting emulsion was injected intradermally into the base of the tail. Each mouse received a total volume of 50 l containing 100 g of Mycobacterium tuberculosis and 100 g of Ag.
Beginning 3 wk after immunization, the mice were evaluated for the development of arthritis three times weekly by an observer who was unaware of the treatment groups. Each mouse limb was graded on a scale of 0 -4 for the development and severity of arthritis. The grading scale has been described previously in detail (14) .
Preparation of control Ags
Native CII was solubilized from fetal bovine articular cartilage by limited proteolysis with pepsin and purified, as described in detail earlier (15) . The peptides representing various CII sequences were chemically synthesized by a solid phase procedure using a peptide synthesizer (model 432; Applied Biosystems, Foster City, CA) as described previously (16) .
Measurement of Ab levels
Mice were bled at 6 wk after immunization and tested for Abs reactive with native CII using a modification of an ELISA previously described (14) . In addition, the profile of epitope specificity of autoreactive anti-mouse CII Abs was analyzed using Mimotope-pin bound peptides as described earlier (17, 18) . Murine CII peptides were synthesized as 112 individual peptides spanning murine CB10 using the Mimotope noncleavable pin technology (Chiron Mimotopes PTY, Clayton, Victoria, Australia). This synthesis scheme produced individual 15-mers, each overlapping by 3 residues. ELISA on native mCII was used to standardize Ab titers before analysis on Mimotope pins. ELISA plates were coated by overnight incubation at 4°C with murine CII at 5 g/ml in phosphate buffer. Both Mimotope pins and standard ELISA plates (Ag) were blocked for 30 min with 2% BSA (Fraction V; Sigma) in ELISA Buffer (1.9 mM NaH 2 PO 4 , 8.4 mM Na 2 HPO 4 , 500 mM NaCl, 0.1% (v/v) Tween 20 (pH 7.4)). Ags were washed (all washes in ELISA buffer) and incubated at 4°C overnight with affinitypurified Abs. After washing, Ags were incubated for 4 h at 4°C with HRPlabeled goat anti-mouse IgG (Sigma) at a dilution of 1:500. ELISAs were developed with OPD substrate (Sigma) for 30 min, and the reactions were stopped with 2.5 N H 2 SO 4 . Abs were removed from the Mimotope blocks according to the manufacturer's instructions. Results are typical of replicate experiments.
T cell hybridomas and IL-2 production assay
Establishment of T cell hybridomas reactive to bovine CB10 and CB8 was previously described (19) . The reaction of the hybridomas was measured by culturing them in RPMI 1640 medium in 96-well microtiter plates using a total volume of 0.3 ml containing 4 ϫ 10 5 syngeneic spleen cells, 10 5 of T hybridoma cells, and 100 g of Ag previously dialyzed against RPMI 1640. The cell cultures were maintained at 37°C in 5% humidified CO 2 for 20 to 24 h, after which the supernatants were harvested and seven 80-l 2-fold serial dilutions were made for determination of IL-2 titers. Four thousand IL-2-dependent cells (HT-2) were added to each supernatant dilution, and, after 16 to 24 h, HT-2 cell viability was evaluated by MTT assay. MTT assay was performed by addition of 10 l/well of MTT solution (5 mg/ml of MTT in PBS) and incubation in 37°C for an additional 3 h. Color was developed by discarding the cell culture supernatant and adding 200 l of developing solution (75% isopropanol in 0.02 N HCl) and incubation at 4°C for 3 to 12 h. OD 690 was measured in an ELISA reader. IL-2 titers were displayed as the last sample dilution that gave half-maximum activity of the HT-2 cells.
Measurement of T cell cytokines: IFN-␥, IL-4, and IL-10
Quantitative measurement of murine IFN-␥, IL-4, and IL-10 was done using a solid-phase ELISA based on the "sandwich" principle. Commercially available kits were used (IFN-␥, Life Technologies, Gaithersburg, MD; and IL-4 and IL-10, Endogen, Boston, MA). Briefly, spleens and lymph nodes from B10.RIII mice immunized 10 to 14 days previously with CII or other Ags emulsified with CFA were individually minced into single cell suspensions in HBSS and washed three times with HBSS. Pooled splenocytes and lymph node cells were then adjusted to a concentration of 5 ϫ 10 6 cells per ml and cultured with 100 g/ml of Ag (synthetic peptides, collagen, or purified protein derivative (PPD)) in DMEM (Life Technologies, Grand Island, NY) supplemented with 5% FBS (HyClone Laboratories, Logan, UT). Supernatants were collected from 72 to 120 h later and either used fresh or after freezing at Ϫ70°C. Supernatant samples were incubated in microtiter wells coated with a mAb recognizing murine IFN-␥, IL-4, or IL-10. Samples were washed, incubated with a preformed detector complex consisting of a biotinylated second mAb to the appropriate cytokine and an antibiotin-alkaline phosphatase conjugate. Absorbance was measured at 405 nm with a spectrophotometer. A standard curve was obtained by plotting the absorbance vs the corresponding concentration of the standards. Values are expressed as pg/ml. Each sample was tested in duplicate wells.
Statistical analysis
The incidence of arthritis in various groups of mice was compared using Fisher's exact test. Ab levels were compared using the Student t test.
Results
Development of recombinant Ags and their recognition by T hybridoma cells
Each of the recombinant peptides was isolated from bacterial culture, and its purity was determined by SDS-PAGE and analysis for endotoxin content. The mutated peptides were identical in m.w. to their respective wild-type (WT) peptides and appeared as single bands by SDS-PAGE (data not shown). To ascertain that the resulting T cell determinants were still functional, we tested each peptide using two T cell hybridomas generated from B10.RIII mice immunized with intact CII. Splenocytes from unimmunized B10.RIII mice were used as APCs. Hybridoma A, which responded to CB10, reacted to the WT rCB10 and to a synthetic peptide representing the immunodominant epitope CII607-621 but failed to react with rCB10 T614A,A617E . Hybridoma B, which responded to CB8, reacted with the synthetic peptide CII442-456, and with rCB10 T614A,A617E , but did not react with rCB10 (Fig. 1) . These data confirmed that we had successfully introduced the CB8 determinant into the CB10 peptide, in effect replacing the original immunodominant determinant.
Induction of arthritis using recombinant peptides
To determine the ability of recombinant peptides to induce arthritis, groups of 10 -12 B10.RIII mice were immunized with each peptide. WT rCB10 was incapable of inducing arthritis as we have previously found for CB10 generated from bovine cartilage. In contrast, the rCB8 was able to induce arthritis in 4 of 12 immunized mice. Mutant rCB10 T614P,A617E was equally as effective as WT rCB8. The arthritis that developed in rCB10 T614P,A617E -immunized mice was clinically severe, with involvement of the ankle, dorsum of the foot, and digits (Fig. 2) . Arthritis was confirmed by histologic examination of selected joints (Fig. 3) .
In addition, mutant rCB10 peptides with substitutions made at either residue 614 or 617 alone in rCB10 were able to induce arthritis, although with a lower incidence. Mice immunized with rCB10 T614P had an incidence of 20% vs 33% for rCB10 T614P,A617E , and rCB10 A617E had an incidence of 10% vs 33% for rCB10 T614P,A617E . In the limited number of mice studied in this experiment, neither single residue substitution caused an incidence of arthritis equal to that of rCB10 T614P,A617E or rCB8. Because of the small number of mice used, it is not possible to be certain whether one of these substitutions makes a more important contribution. Additional studies will be required to address this question. These data suggest that either residues 614 or 617 can contribute to the induction of arthritis, since both recombinant substituted peptides caused at least some arthritis. We have found false positives to be extremely rare.
To confirm the importance of the two substitutions and to further analyze the importance of the context of the epitope, we immunized mice with rCB8 P449T,E452A . This peptide is identical to WT CB8 peptide except for mutations to change residue 449 from a proline to a threonine and residue 452 from glutamic acid to alanine. Thus, we generated a mutant rCB8 that had an epitope similar to the immunodominant epitope of CB10. This peptide was no longer capable of inducing arthritis when used to immunize B10.RIII mice (Table I) .
Characterization of the Ab profiles
Several studies have demonstrated that complement-fixing autoantibodies to CII are required for the development of arthritis and FIGURE 1. Recognition of rCB10 by T cell hybridomas. Shown are the responses of a CB10-specific hybridoma (A) and a CB8-specific hybridoma (B). rCB10 and mutant rCB10 T614P,A617E were generated as described in Materials and Methods. IL-2 is expressed in units per milliliter as described by Kappler and coworkers (30) . CII607-621 and CII442-456 are synthetic peptides representing the sequences of the determinants of CB10 and CB8, respectively. All cultures contained 10 5 T hybridoma cells and 4 ϫ 10 5 B10.RIII spleen cells as an APC source. Supernatants were analyzed after 18 h for IL2 production in a standard HT-2 cell assay. that qualitative differences occur in the Ab responses between susceptible and nonsusceptible strains of mice (18) . We compared the level of Abs generated in response to each of the recombinant peptides by ELISA. Ab levels were measured using plates coated with native bovine CII and serum collected 6 wk after immunization. There was an overall correlation of Ab levels with arthritis in that all of the arthritogenic peptides also generated high Ab levels. In contrast, the nonarthritogenic peptides generated lower levels (Table I) . To compare the topographical distributions of the autoantibodies binding the CB fragments, mice were immunized with either rCB10 or mutant rCB10 T614P,A617E , and sera from individual mice were collected, pooled, and selected using an affinity column specific for native mouse CII. Murine CII-reactive autoantibodies were then cultured with a panel of overlapping peptides immobilized on Mimotope pins spanning the sequence of murine CB10. Interestingly, when sera from mice immunized with mutant rCB10 T614P,A617E or rCB10 were analyzed for the presence of Ab binding sites, the same topographical distribution of Ab binding sites was detected (Fig. 4) . These data suggest that the two mutations created within rCB10 T614P,A617E did not cause Ab specificity to vary from that observed following immunization with rCB10. Although sera from mice immunized with rCB10 T614P,A617E had a higher titer of Ab recognizing the determinants within the CB10 region, there were no qualitative differences in the epitope specificity of autoantibodies.
Characterization of the T cell response
These data support the concept that there are arthritogenic epitopes in CII that can be distinguished from immunogenic epitopes. It is also evident that the primary sequence of the epitope is critical. We have shown that GPAGPAGER forms the core sequence of an epitope that is arthritogenic for B10.RIII mice in the context of CB10 or CB8. In addition, GPAGTAGAR forms the core of an epitope that is immunogenic but not arthritogenic in identical contexts. T cell cytokine responses to each determinant remained to be examined. B10.RIII mice were immunized with bovine CB8, CB10, mutant rCB10 T614P,A617E , or mutant rCB8 P449T,E452A . Spleen and lymph node cells obtained from these mice were cultured in vitro with synthetic peptides CII442-456 and CII607-621, and supernatants were collected and analyzed for the IL-10, IL-4 and IFN-␥ content by ELISA. As shown in Table II , T cell responses following immunization with either CB8 or CB10 were predominantly Th1 to the immunizing determinant, with the greater response occurring to the nonarthritogenic CB10. On the other hand, immunization with mutant rCB10 T614P,A617E more closely resembled the pattern observed following immunization with CB8. The response was predominantly Th1, and a greater response was directed against the CB8 determinant (CII442-456). Th2 cytokine responses, IL-10 and IL-4, were also greater to the CB8 rather than CB10 determinants although lesser quantities 
a Groups of B10.RIII mice were immunized with indicated Ags emulsified in CFA. The critical amino acids in positions 5 and 8 of the core epitopes are shown in bold. The incidence of arthritis was determined at 8 wk postimmunization. All mice were bled at 6 wk postimmunization, and sera were analyzed for IgG Abs to CII by ELISA; the data are presented as units of anti-CII Ab (mean per group Ϯ SD).
‫,ء‬ p Ͻ 0.05 using Student's t test. All groups were compared to the rCB8-immunized sera (positive control).
were produced compared with IFN-␥. These results suggest that the new T cell determinant within mutant rCB10 T614P,A617E induces a cytokine profile more comparable to that generated by CB8 rather than that generated by CB10. In contrast, immunization with rCB8 P449T,E452A led to cytokine responses more closely resembling the pattern observed following immunization with CB10. However, it is possible that the autoreactive component of the immune response is more important to the development of arthritis. To test that possibility, we examined the responses generated against the corresponding murine determinants. In these experiments, lymph nodes and spleen cells from B10.RIII mice immunized with bovine CB8, CB10, rCB8 P449T,E452A , or rCB10 T614P,A617E were cultured with the homologous murine peptides. Immunization with arthritogenic bovine CB8 induced a predominant Th1 (IFN-␥) response when cultured with murine CII442-456 (CB8 determinant). On the other hand, immunization with CB10 induced only a Th2 response when cultured with murine CII607-621 (CB10 determinant). Interestingly, the T cell cytokine response induced following immunization with rCB10 T614P,A617E more closely resembles that induced by immunization with CB8 in that the predominant cytokine response is IFN-␥ when cultured with the murine CB8 determinant and in that greater IFN-␥ and IL-10 responses are generated against the CB8 than the CB10 determinants. Furthermore, cells from mice immunized with rCB8 P449T,E452A showed a profile resembling that of nonarthritogenic CB10 (Table III) .
Discussion
These data establish that a T cell response to particular epitopes within CII is critical for the development of CIA. Although the immunopathogenesis of CIA is only incompletely understood, it is FIGURE 4. Autoantibody profiles. Mice were immunized with bovine CB10 (A), rCB10 T614P,A617E (B), or rCB10 (C), and sera from individual mice were collected and pooled. Autoantibodies reactive with native murine CII were purified by affinity chromatography of the sera on a column of native mouse CII-Sepharose. Autoantibodies were then tested by ELISA for ability to bind to a panel of overlapping peptides immobilized on Mimotope pins spanning the sequence of murine CB10. a B10.RIII mice were immunized with bovine CB8, CB10, rCB10 T614P,A617E , or rCB8 P449T,E452A emulsified in CFA. Ten days later, splenocytes and lymph node cells were harvested, pooled, and cultured with synthetic peptides representing the bovine (b) CII sequence indicated. Supernatants were analyzed by ELISA for IFN-␥, IL-4, and IL-10. Results are reported as pg/ml. Each cytokine experiment was performed at least twice using pooled cells from two to three animals. B10.RIII mice were immunized with bovine CB8, CB10, rCB10 T614P,A617E , or rCB8 P449T,E452A emulsified in CFA. Ten days later, splenocytes and lymph node cells were harvested, pooled, and cultured with synthetic peptides representing the sequence of murine (m) CII. The sequence of the corresponding core epitopes are GPSGPAGER for mCII442-456 and GPSGSTGAR for mCII607-621. Supernatants were analyzed for IFN-␥, IL-4, and IL-10 by ELISA. Results are reported as pg/ml. Each cytokine experiment was performed at least twice using pooled cells from two to three animals.
known that both Ab-and cell-mediated reactions are required for the full expression of arthritis. It has been shown that severe acute arthritis can be transferred with Ab, but disease does not persist (20, 21) . Attempts at cellular transfer have either been unsuccessful (5) or have been able to cause only minimal disease (22) . Attempts to induce disease by immunization with synthetic oligopeptides encompassing T cell epitopes have not been successful, presumably because of the inability to generate sufficient Ab levels. An alternative explanation for the inability of synthetic peptides to induce disease is that posttranslational changes within immunogenic epitopes are required. For example, it has been shown that glycosylation of one amino acid within the immunodominant epitope of CII for DBA/1 mice may be important for reactivity (23) . The role of such posttranslational changes to affect the development of disease is difficult to study even using recombinant peptides since nonmammalian expression systems generally result in proteins or peptides with different glycosylation patterns. This difficulty is overcome using the system we describe in the present paper since the epitopes of interest do not contain glycosylation sites. We have reported elsewhere that bovine CB8 and CB10 produced by this method are immunologically indistinguishable from that of the tissue derived peptides in B10.RIII mice (13) . We were able to use bacterially produced peptides using recombinant DNA technology and to make alterations in the sequence of these peptides with relative ease.
Using the recombinantly produced peptides, we identified core T cell determinants that differed by only two amino acids but that had profoundly different consequences when used as immunogens. Both were immunogenic, but only one was capable of inducing arthritis. It should be noted that the arthritogenic epitope was not sufficient by itself to induce disease, since immunization with synthetic peptides comprising only that epitope does not cause CIA (Data not shown). However, when expressed as a part of a collagenous peptide, the sequence GPAGPAGER is both necessary and sufficient for the induction of CIA in B10.RIII mice.
We then analyzed the in vitro response of T cells to both epitopes to identify critical differences. Analysis of responses following immunization with CB8, CB10, mutant rCB8 P449T,E452A or rCB10 T614P,A617E revealed that, when tested using synthetic peptides representing bovine (immunizing) determinants, there were no detectable differences in the cytokines tested. The critical T cell responses following immunization with these peptides appear to be those generated against the homologous murine determinants, rather than to the immunizing determinant.
The murine homologue of the CII610 -618 immunodominant determinant clearly binds to the I-A r molecule and is capable of stimulating T cells primed with bovine CII. The only difference in the sequences of the bovine CII445-453 and the murine CII445-453 is a conservative substitution of a serine (mouse) residue for an alanine (bovine) residue at position 447. This residue has previously been identified as a T cell interaction site in the antigenic peptide, whereas CII610 -618 (bovine) and the murine CII610 -618 have three differences. These results suggest that the critical response is influenced by the degree of difference between the immunizing Ag and the corresponding murine homologue.
One of the consequences of this altered response is in the level of Ab produced. Each of the arthritogenic peptides induced higher levels of Ab than the nonarthritogenic peptides. The transfer of autoimmune arthritis to naive mice by both polyclonal and mAbs has previously demonstrated the importance of autoantibody production for the initiation of arthritis (16 -18) . High levels of circulating autoantibody to murine CII invariably accompany the development of CIA (19) . However, the degree of similarity between the autoantibody binding patterns induced by the arthritogenic rCB10 T614P,A617E and unmodified rCB10 was unexpected. In recent studies by Brand et al. (18) using DBA/1 mice, a unique subpopulation of autoantibodies that bound to a specific determinant was identified only in CIA-susceptible B10.Q, B10.Q␤BR, and DBA/1 mice. These data suggested that the number and positions of binding sites available might play an important role in initiating disease. Nevertheless, our present data suggest that immunization with either CB8 or CB10 appears to induce an adequate number of Ab specificities for induction of arthritis. The differences appear to be quantitative rather than qualitative.
T cells can be functionally classified as Th1 or Th2 depending on the cytokines they produce (24) . Th1 cells make predominantly IL-2, IFN-␥, and TNF-␣ and mediate inflammatory reactions (25) . Th2 cells produce IL-4, IL-10, and TGF-␤ and suppress some autoimmune responses (26 -28) . In general, a Th1 response predominates in the development of organ-specific autoimmune diseases. Our data are consistent with that hypothesis in that spleen cells from animals given an arthritogenic challenge with CII consistently produced high levels of IFN-␥. In addition, when the nonarthritogenic epitope was analyzed for reactivity with the murine homologue, a Th2 response predominated. These data show that the change in only two amino acids caused a shift in the Th1 vs Th2 cytokine profile. Similar alterations in Th profile due to alterations in peptide ligand have been shown in the autoimmune disease experimental autoimmune encephalomyelitis (29) .
Our data do not address the question of whether the most important response is a proinflammatory Th1 response to the CB8 epitope or an antiinflammatory Th2 response to the CB10 epitope. The data are consistent with either possibility. In addition, additional experiments using individual substitutions at both the 5 and 8 positions will be required to determine the relative contribution of the individual amino acids.
